Theravectys
discovers and develops immunotherapies for the prevention and treatment of cancers and other infectious diseaseses... Read moreTheravectys
discovers and develops immunotherapies for the prevention and treatment of cancers and other infectious diseaseses... Read more
CEO
Ye Tian
News
Jan 06, 2026
Investing.com
Theravectys: French biotech TheraVectys weighs Hong Kong IPO
Oct 04, 2024
FinanzNachrichten
Theravectys: Human Papillomavirus (HPV)-induced Cancers: First Patient Enrolled in Phase I/IIa Clinical Trial for Lenti-HPV-07, the TheraVectys' Therapeutic Vaccine Candidate Against Oropharyngeal and Cervical Cancers
Apr 19, 2019
BioSpace
Theravectys: NOVASEP and THERAVECTYS Enter Into a New License Agreement on DNA Flap Technology for GMP Manufacturing of Lentiviral Vectors
Oct 22, 2018
BioPortfolio
Theravectys: Theravectys SA Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24072018 Prices from USD $250
Aug 04, 2018
BioPortfolio
Theravectys: Theravectys SA Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14062018 Prices from USD $250
Nov 06, 2017
BioPortfolio
Theravectys: Theravectys SA Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 17102017 Prices from USD $250
Sep 05, 2017
BioPortfolio
Theravectys: Theravectys SA Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 22082017 Prices from USD $250
Mar 20, 2017
BioPortfolio
Theravectys: Theravectys SA Pharmaceuticals Healthcare Deals and Alliances Profile Updated 24022017 Prices from USD $250
Jan 19, 2017
BioPortfolio
Theravectys: Theravectys SA Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Mar 08, 2016
in-PharmaTechnologist
Theravectys: HIV vaccine developer Theravectys says GMP suspension at Paris plant won't delay trial
Theravectys Competitors
1
2
3
4
5
6
7
8
9
10